Ken Herrmann, Director at Aktis Oncology, Inc. (AKTS), sold 3,065 shares at $25.21 ($77K) on 2026-07-17, disclosed to the SEC on 2026-07-20.
Open-market sale of $77k AKTS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.